{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:18:55Z","timestamp":1783448335816,"version":"3.55.0"},"reference-count":84,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":277,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022537","name":"Canadian Society of Endocrinology and Metabolism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The incidence of differentiated thyroid cancer (DTC) has increased significantly in recent decades. Following initial diagnosis, DTC patients are classified according to the American Thyroid Association (ATA) as low, intermediate, and high risk for recurrence. Patients in the ATA low recurrence-risk category have a recurrence risk of \u22645%, with 20-year disease-specific mortality of &amp;lt;1%. Accordingly, there has been a shift to de-escalating initial treatment, including the relaxation of thyroid-stimulating hormone suppression. In addition, fewer low-risk patients undergo total thyroidectomy or radioactive iodine therapy. However, the optimal long-term surveillance strategy remains unclear, with many patients continuing follow-up in speciality clinics for many years. In addition, emerging evidence suggests that long-term surveillance can be effectively managed in primary care settings. To enhance understanding among Canadian thyroid practitioners and to improve care for Canadian patients diagnosed with low-risk DTC, we developed this consensus statement by collecting feedback from a multidisciplinary team led by one chairperson (endocrinologist), an additional eight endocrinologists, two surgeons, and one patient partner. This consensus statement reflects current evidence and expert opinion regarding initial management and long-term surveillance of low-risk DTC patients. This work is valuable to Canadian thyroid practitioners as it provides standardized guidelines to ensure optimal care and improved outcomes for low-risk DTC patients.<\/jats:p>","DOI":"10.1530\/etj-25-0072","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T15:24:59Z","timestamp":1747409099000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":3,"title":["Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-268X","authenticated-orcid":true,"given":"Ralf","family":"Paschke","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Cuming School of Medicine, University of Calgary 1 , , ,","place":["Calgary, Alberta, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Ghaznavi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Cuming School of Medicine, University of Calgary 1 , , ,","place":["Calgary, Alberta, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali","family":"Imran","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Dalhousie University 2 , , ,","place":["Halifax, Nova Scotia, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jacquier","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Alberta 3 , , ,","place":["Edmonton, Alberta, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Lochnan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, The Ottawa Hospital, University of Ottawa 4 , , ,","place":["Ottawa, Ontario, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Massicotte","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine H\u00f4pital Fleurimont (CHUS), University of Sherbrooke 5 , , ,","place":["Sherbrooke, Quebec, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Mitmaker","sequence":"additional","affiliation":[{"name":"Department of Surgery, Royal Victoria Hospital (RVH), McGill University 6 , , ,","place":["Montreal, Quebec, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deric","family":"Morrison","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University 7 , , ,","place":["London, Ontario, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-5044","authenticated-orcid":true,"given":"Vicki","family":"Munro","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Dalhousie University 2 , , ,","place":["Halifax, Nova Scotia, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sveistrup","sequence":"additional","affiliation":[{"name":"Director of Education and Publications, Patient Support Volunteer, Thyroid Foundation of Canada 8 , ,","place":["Bath, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam M","family":"Wiseman","sequence":"additional","affiliation":[{"name":"Department of Surgery, St. Paul\u2019s Hospital, University of British Columbia 9 , , ,","place":["Vancouver, British Columbia, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshan","family":"Zahedi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, UHN 10 , ,","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2026070712535563200_bib1","volume-title":"Canadian Cancer Statistics","author":"Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada","year":"2023"},{"key":"2026070712535563200_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/thy.2023.0449","article-title":"All-cause and cause-specific mortality among low-risk differentiated thyroid cancer survivors in the United States","volume":"34","author":"Tran","year":"2024","journal-title":"Thyroid"},{"key":"2026070712535563200_bib3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/thy.2013.0011","article-title":"Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American Thyroid Association and Latin American Thyroid Society risk of recurrence classification systems","volume":"23","author":"Pitoia","year":"2013","journal-title":"Thyroid"},{"key":"2026070712535563200_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/thy.2021.0539","article-title":"Active surveillance versus thyroid surgery for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"key":"2026070712535563200_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026070712535563200_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hed.26960","article-title":"Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: an international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association","volume":"44","author":"Orloff","year":"2022","journal-title":"Head Neck"},{"key":"2026070712535563200_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa2111953","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer","volume":"386","author":"Leboulleux","year":"2022","journal-title":"N Engl J Med"},{"key":"2026070712535563200_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol"},{"key":"2026070712535563200_bib9","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.3390\/curroncol29100606","article-title":"Outcomes of early transition of low-risk thyroid cancer patients from specialist to primary care","volume":"29","author":"Nguyen","year":"2022","journal-title":"Curr Oncol"},{"key":"2026070712535563200_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000494835","article-title":"Primary versus tertiary care Follow-Up of low-risk differentiated thyroid cancer: real-world comparison of outcomes and costs for patients and health care systems","volume":"8","author":"Imran","year":"2019","journal-title":"Eur Thyroid J"},{"key":"2026070712535563200_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clon.2019.01.005","article-title":"Can we discharge dynamically risk-stratified low-risk (excellent response to treatment) thyroid cancer patients after 5 years of follow-up?","volume":"31","author":"Seejore","year":"2019","journal-title":"Clin Oncol"},{"key":"2026070712535563200_bib12","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1530\/EJE-19-0960","article-title":"Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?","volume":"182","author":"Lamartina","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2026070712535563200_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","article-title":"Controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of nuclear medicine and molecular imaging, and the European Thyroid Association","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"2026070712535563200_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026070712535563200_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/thy.2023.0032","article-title":"Large (&gt;4 cm) intrathyroidal encapsulated well-differentiated follicular cell-derived carcinoma without vascular invasion may have negligible risk of recurrence Even when treated with lobectomy alone","volume":"33","author":"Ghossein","year":"2023","journal-title":"Thyroid"},{"key":"2026070712535563200_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.EJ11-0288","article-title":"Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors","volume":"59","author":"Ito","year":"2012","journal-title":"Endocr J"},{"key":"2026070712535563200_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.amjsurg.2020.02.020","article-title":"Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma","volume":"220","author":"Shin","year":"2020","journal-title":"Am J Surg"},{"key":"2026070712535563200_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-014-3899-8","article-title":"Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2026070712535563200_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jamaoto.2021.1976","article-title":"Association of multifocality with prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"147","author":"Kim","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026070712535563200_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/thy.2018.0547","article-title":"Multifocality is not an independent prognostic factor in papillary thyroid cancer: a propensity score-matching analysis","volume":"29","author":"Geron","year":"2019","journal-title":"Thyroid"},{"key":"2026070712535563200_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ejso.2019.02.007","article-title":"Microscopically positive surgical margins and local recurrence in thyroid cancer. A meta-analysis","volume":"45","author":"Sanabria","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2026070712535563200_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jso.24194","article-title":"Does microscopically involved margin increase disease recurrence after curative surgery in papillary thyroid carcinoma?","volume":"113","author":"Lang","year":"2016","journal-title":"J Surg Oncol"},{"key":"2026070712535563200_bib23","volume-title":"AJCC Cancer Staging Manual","author":"Tuttle","year":"2017","edition":"8th edn"},{"key":"2026070712535563200_bib24","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2018-00081","article-title":"Impact of minimal extra-thyroid extension in differentiated thyroid cancer: systematic review and meta-analysis","volume":"1","author":"Diker-Cohen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00423-018-1657-2","article-title":"Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population","volume":"403","author":"Chereau","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"2026070712535563200_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.suronc.2008.04.005","article-title":"Micrometastases in thyroid cancer. An important finding?","volume":"17","author":"Cranshaw","year":"2008","journal-title":"Surg Oncol"},{"key":"2026070712535563200_bib27","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2005-0285","article-title":"Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis","volume":"90","author":"Leboulleux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib28","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4158\/EP-2018-0583","article-title":"Size of the largest metastatic FOCUS to the lymph node IS associated with incomplete response OF PN1 papillary thyroid carcinoma","volume":"25","author":"Deng","year":"2019","journal-title":"Endocr Pract"},{"key":"2026070712535563200_bib29","article-title":"Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases","volume":"14","author":"Xie","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070712535563200_bib30","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1210\/clinem\/dgae327","article-title":"Coexisting RET\/PTC and TERT promoter mutation predict poor prognosis but effective RET and MEK targeting in thyroid cancer","volume":"109","author":"Zhang","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.540238","article-title":"The coexistence of genetic mutations in thyroid carcinoma predicts histopathological factors associated with a poor prognosis: a systematic review and network meta-analysis","volume":"10","author":"Zhao","year":"2020","journal-title":"Front Oncol"},{"key":"2026070712535563200_bib32","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.humpath.2015.08.015","article-title":"Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases","volume":"46","author":"Xu","year":"2015","journal-title":"Hum Pathol"},{"key":"2026070712535563200_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/thy.2021.0424","article-title":"Follicular and Hurthle cell carcinoma: comparison of clinicopathological features and clinical outcomes","volume":"32","author":"Matsuura","year":"2022","journal-title":"Thyroid"},{"key":"2026070712535563200_bib34","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1245\/s10434-022-11401-x","article-title":"Encapsulated angioinvasive follicular thyroid carcinoma: prognostic impact of the extent of vascular invasion","volume":"29","author":"Yamazaki","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2026070712535563200_bib35","volume-title":"WHO Classification of Tumours","author":"IARC Publications Website"},{"key":"2026070712535563200_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1507\/endocrj.EJ20-0692","article-title":"Position paper from the Japan thyroid association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults","volume":"68","author":"Horiguchi","year":"2021","journal-title":"Endocr J"},{"key":"2026070712535563200_bib37","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0244","article-title":"Percutaneous ablation of low-risk papillary thyroid cancer","volume":"30","author":"Tuttle","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026070712535563200_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejso.2017.03.005","article-title":"Thyroid cancer surgery guidelines in an era of de-escalation","volume":"44","author":"Kovatch","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"2026070712535563200_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2022.11.005","article-title":"Position paper from the endocrine task force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma","volume":"179","author":"Koot","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026070712535563200_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/thy.2017.0227","article-title":"Insights into the management of papillary microcarcinoma of the thyroid","volume":"28","author":"Miyauchi","year":"2018","journal-title":"Thyroid"},{"key":"2026070712535563200_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1235006","article-title":"Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance","volume":"14","author":"Ding","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070712535563200_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1185650","article-title":"Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database","volume":"13","author":"Bi","year":"2023","journal-title":"Front Oncol"},{"key":"2026070712535563200_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2023.103994","article-title":"Recommend with caution: a meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance","volume":"44","author":"Issa","year":"2023","journal-title":"Am J Otolaryngol"},{"key":"2026070712535563200_bib44","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1007\/s00423-022-02704-4","article-title":"Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study","volume":"407","author":"R\u00edos","year":"2022","journal-title":"Langenbecks Arch Surg"},{"key":"2026070712535563200_bib45","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1089\/thy.2022.0055","article-title":"The prospective implementation of the 2015 ATA Guidelines and modified ATA recurrence risk stratification system for treatment of differentiated thyroid cancer in a Canadian tertiary care referral setting","volume":"32","author":"Wu","year":"2022","journal-title":"Thyroid"},{"key":"2026070712535563200_bib46","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","article-title":"Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients","volume":"260","author":"Adam","year":"2014","journal-title":"Ann Surg"},{"key":"2026070712535563200_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101550","article-title":"Thyroid and parathyroid surgeon case volume influences patient outcomes: a systematic review","volume":"38","author":"Bedi","year":"2021","journal-title":"Surg Oncol"},{"key":"2026070712535563200_bib48","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.21037\/gs.2017.10.07","article-title":"Tailored surgery according to molecular analysis in differentiated thyroid carcinomas","volume":"7","author":"Miccoli","year":"2018","journal-title":"Gland Surg"},{"key":"2026070712535563200_bib49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/thy.2015.0311","article-title":"Indeterminate single thyroid nodule: synergistic impact of mutational markers and sonographic features in triaging patients to appropriate surgery","volume":"26","author":"De Napoli","year":"2016","journal-title":"Thyroid"},{"key":"2026070712535563200_bib50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoto.2023.1494","article-title":"Prognostic value of preoperative molecular testing and implications for initial surgical management in thyroid nodules harboring suspected (Bethesda V) or known (Bethesda VI) papillary thyroid cancer","volume":"149","author":"Schumm","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026070712535563200_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clon.2012.01.001","article-title":"Iodine or not (IoN) for low-risk differentiated thyroid cancer: the next UK National Cancer Research Network randomised trial following HiLo","volume":"24","author":"Mallick","year":"2012","journal-title":"Clin Oncol"},{"key":"2026070712535563200_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2213-8587(24)00276-6","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial","volume":"13","author":"Leboulleux","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070712535563200_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/cen.14950","article-title":"Radioiodine versus no radioiodine outcomes in low-risk differentiated thyroid cancers: a propensity-score matched analysis","volume":"99","author":"Satapathy","year":"2023","journal-title":"Clin Endocrinol"},{"key":"2026070712535563200_bib54","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1245\/s10434-019-07581-8","article-title":"Utility of early postoperative unstimulated thyroglobulin in influencing decision making in patients with papillary thyroid carcinoma","volume":"26","author":"McDow","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2026070712535563200_bib55","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.3390\/cancers15112976","article-title":"Predictive role of serum thyroglobulin after surgery and before radioactive iodine therapy in patients with thyroid carcinoma","volume":"15","author":"Signore","year":"2023","journal-title":"Cancers"},{"key":"2026070712535563200_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.2021.0666","article-title":"Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"key":"2026070712535563200_bib57","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1210\/jc.2012-3355","article-title":"Variation in the management of thyroid cancer","volume":"98","author":"Haymart","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib58","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1210\/jc.2006-2566","article-title":"Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer","volume":"92","author":"Hovens","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/thy.2021.0404","article-title":"Optimal serum thyrotropin level for patients with papillary thyroid carcinoma after lobectomy","volume":"32","author":"Xu","year":"2022","journal-title":"Thyroid"},{"key":"2026070712535563200_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/thy.2009.0311","article-title":"Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer","volume":"20","author":"Biondi","year":"2010","journal-title":"Thyroid"},{"key":"2026070712535563200_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X21992001","article-title":"Prediction of thyroid hormone replacement following thyroid lobectomy: a long-term retrospective study","volume":"5","author":"Meyer","year":"2021","journal-title":"OTO Open"},{"key":"2026070712535563200_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.surg.2022.05.044","article-title":"Thyroid hormone replacement following lobectomy: long-term institutional analysis 15 years after surgery","volume":"173","author":"Barranco","year":"2023","journal-title":"Surgery"},{"key":"2026070712535563200_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12020-019-02051-3","article-title":"Thyroid hormone therapy in differentiated thyroid cancer","volume":"66","author":"Grani","year":"2019","journal-title":"Endocrine"},{"key":"2026070712535563200_bib64","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3803\/EnM.2020.943","article-title":"A multicenter, randomized, controlled trial for assessing the usefulness of suppressing thyroid stimulating hormone target levels after thyroid lobectomy in low to intermediate risk thyroid cancer patients (MASTER): a study protocol","volume":"36","author":"Lee","year":"2021","journal-title":"Endocrinol Metab"},{"key":"2026070712535563200_bib65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jso.25164","article-title":"The prognostic value of serum thyroid-stimulating hormone level post-lobectomy in low- and intermediate-risk papillary thyroid carcinoma","volume":"118","author":"Park","year":"2018","journal-title":"J Surg Oncol"},{"key":"2026070712535563200_bib66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00268-013-2224-1","article-title":"Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases","volume":"38","author":"Matsuzu","year":"2014","journal-title":"World J Surg"},{"key":"2026070712535563200_bib67","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2015-4290","article-title":"Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine","volume":"101","author":"Momesso","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2005-1185","article-title":"Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy","volume":"91","author":"Torlontano","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib69","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018437","article-title":"Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?","volume":"98","author":"Jeong","year":"2019","journal-title":"Medicine"},{"key":"2026070712535563200_bib70","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/thy.2015.0621","article-title":"Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma","volume":"26","author":"Latrofa","year":"2016","journal-title":"Thyroid"},{"key":"2026070712535563200_bib71","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1210\/jc.2019-00962","article-title":"Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound","volume":"104","author":"Grani","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712535563200_bib72","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1148\/radiol.2021201596","article-title":"Role of sonographic characteristics of thyroid bed lesions identified following thyroidectomy in the diagnosis or exclusion of recurrent cancer","volume":"299","author":"Frates","year":"2021","journal-title":"Radiology"},{"key":"2026070712535563200_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000354537","article-title":"2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer","volume":"2","author":"Leenhardt","year":"2013","journal-title":"Eur Thyroid J"},{"key":"2026070712535563200_bib74","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0110","article-title":"Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study","volume":"12","author":"Wu","year":"2023","journal-title":"Eur Thyroid J"},{"key":"2026070712535563200_bib75","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1515\/cclm-2022-0154","article-title":"Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis","volume":"60","author":"Giovanella","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026070712535563200_bib76","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2010.0178","article-title":"Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system","volume":"20","author":"Tuttle","year":"2010","journal-title":"Thyroid"},{"key":"2026070712535563200_bib77","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0067","article-title":"2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management","volume":"12","author":"Durante","year":"2023","journal-title":"Eur Thyroid J"},{"key":"2026070712535563200_bib78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12020-022-03071-2","article-title":"Long-term follow-up ultrasonography surveillance in a large cohort of patients with papillary thyroid carcinoma","volume":"77","author":"Zhang","year":"2022","journal-title":"Endocrine"},{"key":"2026070712535563200_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12880-018-0253-9","article-title":"Utility of routine ultrasonography follow-up after total thyroidectomy in patients with papillary thyroid carcinoma: a single-center study","volume":"18","author":"Park","year":"2018","journal-title":"BMC Med Imaging"},{"key":"2026070712535563200_bib80","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0284185117700448","article-title":"Analysis of postoperative ultrasonography surveillance after total thyroidectomy in patients with papillary thyroid carcinoma: a multicenter study","volume":"59","author":"Ryoo","year":"2018","journal-title":"Acta Radiol"},{"key":"2026070712535563200_bib81","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/thy.2020.0413","article-title":"Endocrinologist-perceived factors affecting the transition of thyroid cancer patients from specialist to primary care postcancer treatment in Ontario, Canada","volume":"31","author":"Janmohamed","year":"2021","journal-title":"Thyroid"},{"key":"2026070712535563200_bib82","first-page":"2007","article-title":"Thyroid cancer survivors\u2019 perceptions of survivorship care follow-up options: a cross-sectional, mixed-methods survey","volume":"24","author":"Bender","year":"2016","journal-title":"Support Care Cancer"},{"key":"2026070712535563200_bib83","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/cen.14325","article-title":"Frequent neck US in papillary thyroid cancer likely detects non-actionable findings","volume":"94","author":"Sek","year":"2021","journal-title":"Clin Endocrinol"},{"key":"2026070712535563200_bib84","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4158\/EP15851.OR","article-title":"Serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in low-risk papillary thyroid cancer patients","volume":"21","author":"Yang","year":"2015","journal-title":"Endocr Pract"}],"updated-by":[{"DOI":"10.1530\/etj-25-0072e","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000}}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/3\/ETJ-25-0072.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/3\/ETJ-25-0072.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0072\/32889\/etj-25-0072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0072\/32889\/etj-25-0072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:22:16Z","timestamp":1783444936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/3\/e250072\/4430\/Follow-up-and-transition-of-care-for-low"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0072","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"article-number":"e250072"}}